STIL Overexpression and Chromosomal Abnormalities in Lung Cancer
Author Information
Author(s): Ohtsuka Shunsuke, Kato Hisami, Ishikawa Rei, Watanabe Hirofumi, Miyazaki Ryosuke, Katsuragi Shin-ya, Yoshimura Katsuhiro, Yamada Hidetaka, Sakai Yasuhiro, Inoue Yusuke, Takanashi Yusuke, Sekihara Keigo, Funai Kazuhito, Shinmura Kazuya
Primary Institution: Hamamatsu University School of Medicine
Hypothesis
Aberrant STIL expression contributes to the development of non-small-cell lung carcinoma (NSCLC) through chromosomal numerical abnormalities (CNAs).
Conclusion
STIL overexpression is associated with chromosomal numerical abnormalities in NSCLC, likely through centrosome amplification.
Supporting Evidence
- STIL mRNA expression levels were significantly higher in LUAD and LUSC compared to non-cancerous lung tissues.
- Immunohistochemical analysis showed STIL protein overexpression in 64.9% of LUAD cases and 51.0% of LUSC cases.
- STIL overexpression in NSCLC cell lines promoted centrosome amplification and chromosomal instability.
- Elevated STIL expression was associated with chromosomal numerical abnormalities in primary NSCLC.
Takeaway
This study found that a protein called STIL is too much in lung cancer cells, which can cause problems with their chromosomes and make the cancer worse.
Methodology
The study used TCGA dataset analysis, immunohistochemical analysis, and in vitro experiments with NSCLC cell lines to examine STIL expression and its association with CNAs.
Limitations
The findings have not been confirmed in primary NSCLC tissues or patient-derived models, and the precise molecular mechanisms underlying the relationships were not explored.
Participant Demographics
The study analyzed 268 primary lung adenocarcinoma (LUAD) cases and 98 primary lung squamous cell carcinoma (LUSC) cases.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website